News

Tergus Pharma rated as one of the fastest growing 500 private companies

(May 4, 2017)

Read More

How Complete is Your Regulatory Knowledge?

(November 4, 2016)

A thorough knowledge of regulatory issues is vital. Having a solid grasp of the regulatory environment

Read More

Tergus CEO to Speak at 5th Annual Innovations in Dermatological Sciences Conference

(September 23, 2016)

Prestigious conference presented by the Center for Dermal Research at Rutgers University

Read More

Tergus CEO to Speak at 5th Annual Innovations in Dermatological Sciences Conference

(September 5, 2016)

Prestigious conference presented by the Center for Dermal Research at Rutgers University

Read More

Tergus Hires Seasoned Director of Business Development

(July 27, 2016)

Graham Mott brings experience and a track record of success to Tergus…

Read More

Tergus COO Honored by Alma Mater

(May 19, 2016)

Kailas Thakker, PhD, was been awarded a Distinguished Alumnus Award…

Read More

Tergus Creates Several Key Positions and Attracts Top Talent

(April 20, 2016)

James Varner and Lance Rogers will lead analytical R&D and project management…

Read More

Tergus Hires Top Manufacturing Executive

(January 13, 2016)

Ashik Pavagadhi will take on Head of Manufacturing Operations role…

Read More

Tergus Hires Leading Sales and Marketing Executive

(December 10, 2015)

Michele Nathan Borek has more than 20 years of experience in creating growth for life science companies…

Read More

New FDA Request for Quality Metrics

(July 30, 2015)

The FDA has released a draft of its Request for Quality Metrics, a guide for the pharmaceutical industry. The document contains non-binding recommendations, outlines a set of measurements to evaluate the quality of the facilities and the processes that manufacturers use to make regulated drugs and biologics…

Read More

Indoor Tanning Rates Decrease in U.S.

(July 16, 2015)

According to Healio Dermatology (http://goo.gl/hTYBCy) of a recent article in JAMA Dermatology, people are turning away from indoor tanning. Using National Health Interview Survey data, researchers discovered the drop. According to the article, “Between 2010 and 2013, indoor tanning reduced from 5.5% to 4.2% among all adults (P < .001). Among women, the rate reduced…

Read More

Incidence of Melanoma In Situ and Invasive Melanoma on the Rise

(July 1, 2015)

A recent article in JAMA Dermatology (Helvind NM, et al. JAMA Dermatol. 2015;doi:10.1001/jamadermatol.2015.1481.) reported that incidences of melanoma in situ and invasive melanoma are on the rise.

Read More

The View from the Floor of the World Congress of Dermatology Conference

(June 10, 2015)

The World Congress of Dermatology (www.derm2015.org) has convened in Vancouver and the sessions and exhibits are keeping Tergus CEO Vijendra Nalamothu busy. His posts from the floor have revealed some interesting trends.

Read More

Tergus Gears Up for a Busy June

(May 2015)

Product Development Workshop at the Cumberland Hotel in London — on June 23rd and 24th, 2015
June is looking to be a very busy month for Tergus, particularly with CEO Vijendra Nalamothu speaking at the 6th AGAH Dermatological Product Development Workshop. The workshop will be held at the Cumberland Hotel in London on June 23rd and 24th and will be hosted by The Association for Applied Human Pharmacology.

Read More

Tergus CEO to Speak at 6th Dermatological Product Development Workshop

(May 2015)

Research Triangle Park, North Carolina — May 20th, 2015
Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I – III cGMP clinical supply manufacturing, is excited to announce that CEO and co-founder Vijendra Nalamothu is speaking at the 6th Dermatological Product Development Workshop in London, UK. He is also acting as a member of the steering committee for the event.

Read More

Tergus Hires Quality Assurance (QA) Executive — Kelly Thomas has 18 years of experience in quality control and cGMP

(April 2015)

We have some great news to share:
Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I – III cGMP clinical supply manufacturing, has hired Ms. Kelly Thomas to head the company’s Quality Assurance (QA) and Compliance departments. Ms. Thomas has more than 18 years of experience in developing, implementing and managing QA and cGMP operations.

Read More

TOPICAL DELIVERY — The Importance of the Right Formulation in Topical Drug Development

(January/February 2015)

drugTopical formulations for pharmaceutical delivery are becoming increasingly popular. Topical delivery has a number of advantages: the ability to deliver drug substance more selectively to a specific site, avoiding fluctuations in drug levels, inter- and intra-patient variations, improved compliance, and an enhanced suitability for self-medication.

Read More

2014 AAPS Annual Meeting and Exposition

(November 2014)

More than just a CRO, at Tergus Pharma we work with our client’s development team as an extension of their own laboratory. In doing so, we focus on our core value — our team’s technical leadership experience in the dermatological field. Our unparalleled expertise ranges from Concept to Commercialization. We are experts in Quality by Design (QbD), risk-based approaches, strategic planning and innovative drug product design.

Read More

The Company Has Added State-of-the-Art Equipment That Will Further Enhance Manufacturing Functionality and Capability.

(September 2014)

Tergus (www.terguspharma.com) has acquired cutting-edge equipment that will aid in manufacturing topical pharmaceutical supplies for clinical trials. The company, currently working from a state-of-the-art facility at Research Triangle Park area of Durham, North Carolina, delivers topical pharmaceutical formulation, analytical R&D, IVRT testing and manufacturing.

Read More

Tergus has positioned itself for continued growth and expansion in the coming months.

(July 2014)

Research Triangle Park, North Carolina — July 21, 2014 — Tergus (www.terguspharma.com) has positioned itself for continued growth and expansion in the coming months. The company, which delivers dermatological product development, research and analysis, recently opened a state-of-the-art facility at Research Triangle Park in Durham, North Carolina. The company has a stellar, 18-year track record of successfully providing comprehensive services as well as regulatory guidance, documentation and support.

Read More

Tergus Pharma welcomes Michael Branciforti

(April 2013)

Research Triangle Park, North Carolina, 3rd April 2013. Tergus Pharma, an independent contract product development organization specializing in topical drug products, is pleased to announce the appointment of Mr. Michael Branciforti to their executive team.

Read More

New company announcement:

(June 2012)

Tergus Pharma. Analytical Solutions, Inc. Expands, Changing Name to Tergus Pharma. New Name Reflects Expanded Services in Dermatology Product Development.

Read More

Tergus Pharma (formerly ASI) Announces Complete Topical Product Development Services

(October 2011)

New partnership expands the capabilities of Tergus Pharma to offer topical drug development services from concept to commercialization.

Read More

Industry News

(August 2010)

Dr. Kailas Thakker to Speak Globally on the Use of Franz Diffusion Cells in Drug Product Performance Testing

Read More

Tergus Pharma (ASI) Celebrates 15 Years in Business

(April 2009)

RTP-based company delivering analytical and formulation or CMC services to the Pharmaceutical Industry and establishing worldwide leadership in IVRT testing design achieves operating milestone accomplished by few.

Read More